Glycoprotein Ib ␣ (GpIb␣), a trans-membrane glycoprotein, is expressed on the surface of megakaryocytes and platelets, where, in association with glycoprotein Ib , glycoprotein V, and glycoprotein IX, it normally forms the von Willebrand factor receptor (vWFR). A fully functional vWFR is necessary for platelet attachment, aggregation, and activation and has also been shown to regulate megakaryocyte ploidy. We have recently shown that the gene encoding GpIb␣ is a transcriptional target for the c-Myc oncoprotein and is more widely expressed than previously thought, with particularly high levels occurring in transformed cells. Indeed, GpIb␣ can substitute for c-Myc in promoting growth, transformation, and genomic instability. In the current work, we have demonstrated that, despite the promiscuous expression of GpIb␣, other vWFR subunits remain largely restricted to megakaryocytes. We have characterized a panel of GpIb␣ mutants and shown that some regions of the protein essential for vWFR activity are not necessary for c-Myc-like functions. Specifically, the six C-terminal amino acids of the cytoplasmic domain, which mediate vWFR signaling, are entirely dispensible for the c-Myc-like functions of GpIb␣. Instead, these require a more membraneproximal filamin-binding domain. Also important is the GpIb␣ signal peptide, which, in the absence of other vWFR subunits, directs GpIb␣ to the endoplasmic reticulum rather than the membrane. Together, these results provide strong evidence that the domains of GpIb␣ mediating c-Myc-like functions are modular, genetically distinct, and independent of those involved in vWFR signaling.